SCHEMBL30407109

SCHEMBL30407109

COCCOCCOCCOCCOCCOCCOCCOCCOCCOCC(=O)NCCCC[C@H](NC(=O)CCCNC(=O)[C@H]([C@@H](C(=O)NCCCC(=O)N[C@@H](CCCCNC(=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOC)C(=O)NCCCC(=O)NCC(=O)NCC(=O)O)N1C(=O)C=CC1=O)N1C(=O)C=CC1=O)C(=O)NCCCC(=O)NCC(=O)NCC(=O)O

nearest known ligand 0.51

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 8/20 0.51
▸ GLO1 Q04760 1/20 0.34
▸ SIRT2 Q8IXJ6 2/20 0.34
▸ PTPN1 P18031 1/20 0.34
▸ CCKAR P32238 5/20 0.33
▸ CCKBR P32239 5/20 0.33
▸ ROCK2 O75116 1/20 0.33
▸ TPSAB1 Q15661 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30407756 0.98 GLP1R (0.49) GLP1RGLO1SIRT2PTPN1CCKAR
SCHEMBL30407384 0.98 GLP1R (0.49) GLP1RGLO1SIRT2PTPN1CCKAR
SCHEMBL29467601 0.98 GLP1R (0.49) GLP1RGLO1SIRT2PTPN1CCKAR
SCHEMBL30407083 0.98 GLP1R (0.49) GLP1RGLO1SIRT2PTPN1CCKAR
SCHEMBL30407255 0.98 GLP1R (0.52) GLP1RGLO1SIRT2PTPN1ROCK2
SCHEMBL30407395 0.96 GLP1R (0.51) GLP1RGLO1SIRT2PTPN1CCKAR
SCHEMBL30408052 0.91 GLP1R (0.49) GLP1RSIRT2CCKARCCKBR
SCHEMBL30407599 0.91 GLP1R (0.50) GLP1RGLO1SIRT2CCKARCCKBR
SCHEMBL30407169 0.91 GLP1R (0.50) GLP1RGLO1SIRT2CCKARCCKBR
SCHEMBL30407104 0.91 GLP1R (0.46) GLP1RCCKARCCKBRROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4426741-A1 BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE Hangzhou DAC Biotech Co., Ltd. (CN) 2024-09-11 — — EP disclosed
EP-4426729-A1 SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE Hangzhou Dac Biotech Co., Ltd. (CN) 2024-09-11 — — EP disclosed
WO-2023078021-A1 BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-05-11 — — WO disclosed
WO-2023078273-A1 SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-05-11 — — WO disclosed
Send feedback